Validation and Clinical Utility of the hERG IC50:Cmax Ratio to Determine the Risk of Drug-Induced Torsades de Pointes: A Meta-Analysis-Reference-Cited by-同舟云学术

Validation and Clinical Utility of the hERG IC50:Cmax Ratio to Determine the Risk of Drug-Induced Torsades de Pointes: A Meta-Analysis

Published:2018-02-19 Issue:3 Volume:38 Page:341-348
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Lehmann David F.¹^ORCID,Eggleston William D.²³,Wang Dongliang⁴

Affiliation:

1. Department of Medicine; SUNY Upstate Medical University; Syracuse New York

2. Department of Emergency Medicine; SUNY Upstate Medical University; Syracuse New York

3. Department of Pharmacy Practice; Binghamton University School of Pharmacy and Pharmaceutical Sciences; Binghamton New York

4. Department of Public Health and Preventive Medicine; SUNY Upstate Medical University; Syracuse New York

Publisher

Wiley

Subject

Pharmacology (medical)

Reference55 articles.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献